COPD News wrote "Therapeutic Solutions International (TSOI) has launched a pharmaceutical spin-off — Breathe Biologics — that will take the lead in developing and marketing therapies for chronic obstructive pulmonary disease (COPD), including JadiCell, its investigational stem cell therapy.
TSOI has licensed to Breathe Biologics the investigational new drug (IND) application for its stem cell therapy that it submitted to the U.S. Food and Drug Administration (FDA) asking permission to start testing the therapy in human trials."
When do you think they will start a trial? Does anybody have a contact at Breathe Biologics?